Catalog Home Page

Publications: Mitrpant, Chalermchai

Stats for Mitrpant, Chalermchai
Export as [feed] RSS
Group by: Item Type | Year
Number of items: 19.

Journal Article

Flynn, L.L., Mitrpant, C., Pitout, I.L., Fletcher, S. and Wilton, S.D. (2018) Antisense oligonucleotide mediated terminal intron retention of the SMN2 transcript. Molecular Therapy - Nucleic Acids, 11 . pp. 91-102.

Luo, Y-B, Mitrpant, C., Adams, A.M., Johnsen, R.D., Fletcher, S., Mastaglia, F.L. and Wilton, S.D. (2014) Antisense oligonucleotide induction of progerin in human myogenic cells. PLoS ONE, 9 (6).

Rojana-udomsart, A., Mitrpant, C., James, I., Witt, C., Needham, M., Day, T., Kiers, L., Corbett, A., Martinez, P., Wilton, S.D. and Mastaglia, F.L. (2013) Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis. Journal of Neuroimmunology, 254 (1-2). pp. 174-177.

Rojana-udomsart, A., Mitrpant, C., Bundell, C., Price, L., Luo, Y-B, Fabian, V., Wilton, S.D., Hollingsworth, P. and Mastaglia, F.L. (2013) Complement-mediated muscle cell lysis: A possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). Journal of Neuroimmunology, 264 (1-2). pp. 65-70.

Buratti, E., Mitrpant, C., Porensky, P., Zhou, H., Price, L., Muntoni, F., Fletcher, S., Wilton, S.D. and Burghes, A.H.M. (2013) Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: Towards a treatment for spinal muscular atrophy. PLoS ONE, 8 (4). e62114.

Luo, Y-B, Mitrpant, C., Johnsen, R.D., Fabian, V.A., Fletcher, S., Mastaglia, F.L. and Wilton, S.D. (2013) Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles. International Journal of Clinical and Experimental Pathology, 6 (12). pp. 2778-2786.

Luo, Y-B, Mitrpant, C., Johnsen, R., Fabian, V., Needham, M., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis. International Journal of Clinical and Experimental Pathology, 6 (9). pp. 1723-1733.

Zhou, H., Janghra, N., Mitrpant, C., Dickinson, R.L., Anthony, K., Price, L., Eperon, I.C., Wilton, S.D., Morgan, J. and Muntoni, F. (2013) A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice. Human Gene Therapy, 24 (3). pp. 331-342.

Anderton, R.S., Price, L.L., Turner, B.J., Meloni, B.P., Mitrpant, C., Mastaglia, F.L., Goh, C., Wilton, S.D. and Boulos, S. (2012) Co-regulation of survival of motor neuron and Bcl-xL expression: Implications for neuroprotection in spinal muscular atrophy. Neuroscience, 220 . pp. 228-236.

Porensky, P.N., Mitrpant, C., McGovern, V.L., Bevan, A.K., Foust, K.D., Kaspar, B.K., Wilton, S.D. and Burghes, A.H.M. (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Human Molecular Genetics, 21 (7). pp. 1625-1638.

Mitrpant, C., Fletcher, S., Iversen, P.L. and Wilton, S.D. (2009) By-passing the nonsense mutation in the 4CV mouse model of muscular dystrophy by induced exon skipping. The Journal of Gene Medicine, 11 (1). pp. 46-56.

Mitrpant, C., Fletcher, S. and Wilton, S. (2009) Personalised genetic intervention for duchenne muscular dystrophy: Antisense oligomers and exon skipping. Current Molecular Pharmacology, 2 (1). pp. 110-121.

Mitrpant, C., Adams, A.M., Meloni, P.L., Muntoni, F., Fletcher, S. and Wilton, S.D. (2009) Rational design of antisense oligomers to induce dystrophin exon skipping. Molecular Therapy, 17 (8). pp. 1418-1426.

Wilton, S., Mitrpant, C., Meloni, P., Adams, A. and Fletcher, S. (2008) T.P.2.01 Antisense oligomer design: Targeting and assay systems. Neuromuscular Disorders, 18 (9-10). p. 756.

Fletcher, S., Steinhaus, J., Mitrpant, C., Meloni, P. and Wilton, S. (2008) T.P.2.09 Induced exon skipping in normal and mdx muscle. Neuromuscular Disorders, 18 (9-10). pp. 758-759.

Conference Item

Fletcher, S., Adams, A.M., Johnsen, R.D., Greer, K., Mitrpant, C., Moulton, H.M., Kole, R. and Wilton, S.D. (2010) Concurrent administration of prednisolone and peptide conjugated PMOs is not contra-indicated in the MDX mouse. In: 15th International Congress of The World Muscle Society, 12 - 16 October 2010, Kumamoto, Japan.

Mitrpant, C., Fragall, C., Fletcher, S. and Wilton, S.D. (2009) Antisense oligomer induced splice manipulation of Survival Motor Neuron exon 7. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Wilton, S., Adams, A.M., Meloni, P., Johnsen, R., Forrest, S., Greer, K., Stone, L., Mitrpant, C. and Fletcher, S. (2009) Splice intervention to treat duchenne muscular dystrophy and beyond. In: 33rd HGSA Annual Scientific Meeting, 3 - 6 May 2009, Fremantle, Western Australia.

Mitrpant, C., Fletcher, S., Meredith, C., Bittles, A. and Wilton, S. (2007) Antisense induced exon skipping restores dystrophin in the 4CV mouse model of muscular dystrophy. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

This list was generated on Tue Aug 20 05:22:47 2019 UTC.